Obesity and Copd Severity: An Observational Cross-Sectional Study
Main Article Content
Abstract
INTRODUCTION: COPD is a frequent chronic condition. Although the fact that losing weight is common in individuals with COPD, previous research has shown that approximately 65 percent of COPD patients are overweight or obese.1 Body mass index is a substantial risk factor for mortality from COPD. However, trustworthy data on stratified weight recommendations for COPD remain scarce. The purpose of this research is to determine the relationship between BMI and COPD severity grades so as to enhance patient care.2 The study's goal was to determine BMI in persons with COPD.
AIM: To investigate BMI in individuals with COPD.
METHOD AND MATERIAL: For a duration of one and a half years, an observational cross-sectional study was conducted in our Tertiary Care Centre's Respiratory Medicine department. The study included 102 people over the age of 40 who had COPD according to spirometry (FEV1/FVC <0.7). The complete information provided by patients was attained and analysed using statistical tools.
RESULTS: In this study, 102 people participated. The majority of patients (46 in total) were aged 61-70 years. In the research, 35 patients (34.3%) were overweight and 67 (65.7%) had normal BMI. Overweight was seen in 25% of Stage 1 COPD patients, 29% were with Stage 2, 44.4% with Stage 3, and 43.7% with Stage 4.
CONCLUSION:These data suggest that the rise in BMI and overweight is associated with an elevation in COPD severity. Stages 3 and 4 of COPD had the largest prevalence of overweight people, based on GOLD staging.
Article Details
References
Verberne LD, Leemrijse CJ, Swinkels IC, van Dijk CE, de Bakker DH, Nielen MM. Overweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice. NPJ primary care respiratory medicine. 2017 Nov 22;27(1):63.
Huber MB, Kurz C, Kirsch F, Schwarzkopf L, Schramm A, Leidl R. The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data. Respiratory Research. 2020 Dec;21(1):1-0.
O’Reilly S. Chronic Obstructive Pulmonary Disease. American Journal of Lifestyle Medicine. 2017 Jul;11(4):296–302.
Magnussen H, Watz H. Systemic Inflammation in Chronic Obstructive Pulmonary Disease and Asthma: Relation with Comorbidities. Proceedings of the American Thoracic Society. 2009 Dec 15;6(8):648–51.
Franssen FM, O’Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5· Obesity and COPD. Thorax. 2008 Dec 1;63(12):1110-7.
Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. International journal of general medicine. 2010 Oct 20:335-43.
7.Fuller-Thomson E, Howden KE, Fuller-Thomson LR, Agbeyaka S. A strong graded relationship between level of obesity and COPD: findings from a national population-based study of lifelong nonsmokers. Journal of Obesity. 2018 Nov 20;2018.
Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J et al. Metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25:226–232.
Vujic T, Nagorni O, Maric G, Popovic L, Jankovic J. Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation. Hippokratia. 2016 Apr;20(2):110.
Lambert AA, Putcha N, Drummond MB, Boriek AM, Hanania NA, Kim V, Kinney GL, McDonald ML, Brigham EP, Wise RA, McCormack MC. Obesity is associated with increased morbidity in moderate to severe COPD. Chest. 2017 Jan 1;151(1):68-77.